Keith A. Fowler, R Ph, DVM
About Keith A. Fowler, R Ph, DVM
Keith A. Fowler, R Ph, DVM, is the Director at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in global drug safety and clinical veterinary medicine.
Current Role at Bristol Myers Squibb
Keith A. Fowler currently serves as Director at Bristol Myers Squibb in Summit, New Jersey, United States. His responsibilities include providing first-line level support to Lead Product Safety Physicians in monitoring and managing the safety profile of assigned products. He leads safety surveillance activities and coordinates Safety Management Team minutes and communications, preparing materials for assigned products.
Past Experience at Celgene
From 2013 to 2019, Keith A. Fowler worked at Celgene as Associate Director of Global Drug Safety & Risk Management (Safety Science) in Summit, NJ. During this time, he led successful NDA/MAA submission teams for two hematology/oncology products, resulting in their approval. He also contributed to process-improvement and cross-functional initiatives in Safety Science and Global Drug Safety and Risk Management.
Employment History with Merck and Pfizer
Keith A. Fowler held positions at several prominent pharmaceutical companies, including Merck and Pfizer. At Merck, he worked for 8 months as a Clinical and Regulatory Analyst-Aggregate Reports in Springfield, NJ from 2011 to 2012. At Pfizer Global Research and Development, he served as Associate Director from 2008 to 2010 and as Clinical Veterinarian from 2001 to 2008. His tenure at Pfizer included roles in both Groton, CT and other locations.
Educational Background
Keith A. Fowler has a diverse educational background in pharmacy, veterinary medicine, and pharmaceutical medicine. He earned a BS in Pharmacy from Rutgers University (1982-1987), a Doctor of Veterinary Medicine (DVM) from Tuskegee University (1990-1994), residency in Laboratory Animal Medicine and Pathology from Emory University School of Medicine (1996-1998), and a Masters of Science in Pharmaceutical Medicine from Hibernia College (2008-2010).
Industry Knowledge and Initiatives
Keith A. Fowler has a strong working knowledge of ICH, GCP, and GLP guidelines, which support regulatory submissions and product life-cycle development. He has implemented IND Safety Reporting Guidelines and CTFG IB-Reference Safety Information Implementation. He is also experienced in managing and training new colleagues to facilitate their acclimation to roles and responsibilities in support of clinical teams and Lead Product Safety Physicians.